These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 5927765)

  • 1. Acetate metabolism in the nervous system. N-acetyl-L-aspartic acid and the biosynthesis of brain lipids.
    D'Adamo AF; Yatsu FM
    J Neurochem; 1966 Oct; 13(10):961-5. PubMed ID: 5927765
    [No Abstract]   [Full Text] [Related]  

  • 2. Deep mutational scanning reveals a correlation between degradation and toxicity of thousands of aspartoacylase variants.
    Grønbæk-Thygesen M; Voutsinos V; Johansson KE; Schulze TK; Cagiada M; Pedersen L; Clausen L; Nariya S; Powell RL; Stein A; Fowler DM; Lindorff-Larsen K; Hartmann-Petersen R
    Nat Commun; 2024 May; 15(1):4026. PubMed ID: 38740822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.
    Grønbæk-Thygesen M; Hartmann-Petersen R
    Cell Biosci; 2024 Apr; 14(1):45. PubMed ID: 38582917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery.
    Daniele G; Campi B; Saba A; Codini S; Ciccarone A; Giusti L; Del Prato S; Esterline RL; Ferrannini E
    Front Endocrinol (Lausanne); 2020; 11():216. PubMed ID: 32362872
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Hofer DC; Zirkovits G; Pelzmann HJ; Huber K; Pessentheiner AR; Xia W; Uno K; Miyazaki T; Kon K; Tsuneki H; Pendl T; Zoughbi WA; Madreiter-Sokolowski CT; Trausinger G; Abdellatif M; Schoiswohl G; Schreiber R; Eisenberg T; Magnes C; Sedej S; Eckhardt M; Sasahara M; Sasaoka T; Nitta A; Hoefler G; Graier WF; Kratky D; Auwerx J; Bogner-Strauss JG
    FASEB J; 2019 Dec; 33(12):13808-13824. PubMed ID: 31638418
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing Cerebral Metabolism in the Immature Rodent: From Extracts to Real-Time Assessments.
    Mikrogeorgiou A; Xu D; Ferriero DM; Vannucci SJ
    Dev Neurosci; 2018; 40(5-6):463-474. PubMed ID: 30991389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
    von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
    Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in neurochemical profiles of two gadid species under ocean warming and acidification.
    Schmidt M; Windisch HS; Ludwichowski KU; Seegert SLL; Pörtner HO; Storch D; Bock C
    Front Zool; 2017; 14():49. PubMed ID: 29093740
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Bogner-Strauss JG
    Front Endocrinol (Lausanne); 2017; 8():240. PubMed ID: 28979238
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing White Matter Microstructure in Brain Regions with Different Myelin Architecture Using MRI.
    Groeschel S; Hagberg GE; Schultz T; Balla DZ; Klose U; Hauser TK; Nägele T; Bieri O; Prasloski T; MacKay AL; Krägeloh-Mann I; Scheffler K
    PLoS One; 2016; 11(11):e0167274. PubMed ID: 27898701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
    Maier H; Wang-Eckhardt L; Hartmann D; Gieselmann V; Eckhardt M
    J Neurosci; 2015 Oct; 35(43):14501-16. PubMed ID: 26511242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitochondrial aspartate/glutamate carrier isoform 1 gene expression is regulated by CREB in neuronal cells.
    Menga A; Iacobazzi V; Infantino V; Avantaggiati ML; Palmieri F
    Int J Biochem Cell Biol; 2015 Mar; 60():157-66. PubMed ID: 25597433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation.
    Moffett JR; Arun P; Ariyannur PS; Namboodiri AM
    Front Neuroenergetics; 2013 Dec; 5():11. PubMed ID: 24421768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.
    Rae CD
    Neurochem Res; 2014 Jan; 39(1):1-36. PubMed ID: 24258018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAT8L (N-acetyltransferase 8-like) accelerates lipid turnover and increases energy expenditure in brown adipocytes.
    Pessentheiner AR; Pelzmann HJ; Walenta E; Schweiger M; Groschner LN; Graier WF; Kolb D; Uno K; Miyazaki T; Nitta A; Rieder D; Prokesch A; Bogner-Strauss JG
    J Biol Chem; 2013 Dec; 288(50):36040-51. PubMed ID: 24155240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after gene therapy for canavan disease.
    Leone P; Shera D; McPhee SW; Francis JS; Kolodny EH; Bilaniuk LT; Wang DJ; Assadi M; Goldfarb O; Goldman HW; Freese A; Young D; During MJ; Samulski RJ; Janson CG
    Sci Transl Med; 2012 Dec; 4(165):165ra163. PubMed ID: 23253610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism, compartmentation, transport and production of acetate in the cortical brain tissue slice.
    Rae C; Fekete AD; Kashem MA; Nasrallah FA; Bröer S
    Neurochem Res; 2012 Nov; 37(11):2541-53. PubMed ID: 22851350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondrial aspartate/glutamate carrier AGC1 and calcium homeostasis: physiological links and abnormalities in autism.
    Napolioni V; Persico AM; Porcelli V; Palmieri L
    Mol Neurobiol; 2011 Aug; 44(1):83-92. PubMed ID: 21691713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive aspartoacylase expression in the rat central nervous system.
    Moffett JR; Arun P; Ariyannur PS; Garbern JY; Jacobowitz DM; Namboodiri AM
    Glia; 2011 Oct; 59(10):1414-34. PubMed ID: 21598311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of aspartoacylase for potential use in enzyme replacement therapy for the treatment of Canavan disease.
    Zano S; Malik R; Szucs S; Matalon R; Viola RE
    Mol Genet Metab; 2011 Feb; 102(2):176-80. PubMed ID: 21095151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.